TrialAntimicrobial agents and chemotherapy2006

Absence of cochleotoxicity measured by standard and high-frequency pure tone audiometry in a trial of once- versus three-times-daily tobramycin in cystic fibrosis patients.

Michael Mulheran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.